Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1980 Jun;69(2):265P–346P.

Proceedings of the British Pharmacological Society. 17th-19th December, 1979: University of London (Institute of Education).

PMCID: PMC2044265  PMID: 7437639

Full text

PDF
265P

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Andén N. E., Grabowska M. FLA 136: selective agonist at central alpha-adrenoreceptors mediating changes in the turnover of noradrenaline. Naunyn Schmiedebergs Arch Pharmacol. 1977 Jul;298(3):239–243. doi: 10.1007/BF00500894. [DOI] [PubMed] [Google Scholar]
  4. Andén N. E., Grabowska M., Strömbom U. Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents. Naunyn Schmiedebergs Arch Pharmacol. 1976;292(1):43–52. doi: 10.1007/BF00506488. [DOI] [PubMed] [Google Scholar]
  5. Aprigliano O., Hermsmeyer K. In vitro denervation of the portal vein and caudal artery of the rat. J Pharmacol Exp Ther. 1976 Sep;198(3):568–577. [PubMed] [Google Scholar]
  6. Ballantyne B., Gazzard M. F., Robson D. C., Swanston D. W. Concentrations of 2-hydroxyiminomethyl-N-methylpyridinium ion in plasma and aqueous humor as indices of the toxicity of pralidoxime mesylate (P2S) for the rabbit. Toxicol Appl Pharmacol. 1975 Sep;33(3):559–567. doi: 10.1016/0041-008x(75)90080-0. [DOI] [PubMed] [Google Scholar]
  7. Baumann P. A., Maître L. Blockade of presynaptic alpha-receptors and of amine uptake in the rat brain by the antidepressant mianserine. Naunyn Schmiedebergs Arch Pharmacol. 1977 Oct;300(1):31–37. doi: 10.1007/BF00505077. [DOI] [PubMed] [Google Scholar]
  8. Baumann P. A., Maître L. Blockade of presynaptic alpha-receptors and of amine uptake in the rat brain by the antidepressant mianserine. Naunyn Schmiedebergs Arch Pharmacol. 1977 Oct;300(1):31–37. doi: 10.1007/BF00505077. [DOI] [PubMed] [Google Scholar]
  9. Baumgarten H. G., Lange W. Extrinsic adrenergic innervation of the extrahepatic biliary duct system in guinea-pigs, cats and rhesus monkeys. Z Zellforsch Mikrosk Anat. 1969 Sep 22;100(4):606–615. doi: 10.1007/BF00344379. [DOI] [PubMed] [Google Scholar]
  10. Bedard P., Pycock C. J. "Wet-dog" shake behaviour in the rat: a possible quantitative model of central 5-hydroxytryptamine activity. Neuropharmacology. 1977 Oct;16(10):663–670. doi: 10.1016/0028-3908(77)90117-4. [DOI] [PubMed] [Google Scholar]
  11. Bennett A., Posner J. Studies on prostaglandin antagonists. Br J Pharmacol. 1971 Aug;42(4):584–594. doi: 10.1111/j.1476-5381.1971.tb07142.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bergström S., Carlson L. A., Weeks J. R. The prostaglandins: a family of biologically active lipids. Pharmacol Rev. 1968 Mar;20(1):1–48. [PubMed] [Google Scholar]
  13. Besson J., Rotsztejn W., Laburthe M., Epelbaum J., Beaudet A., Kordon C., Rosselin G. Vasoactive intestinal peptide (VIP): brain distribution, subcellular localization and effect of deafferentation of the hypothalamus in male rats. Brain Res. 1979 Apr 6;165(1):79–85. doi: 10.1016/0006-8993(79)90046-5. [DOI] [PubMed] [Google Scholar]
  14. Beswick S. P., Davies J. S., Goadby P. Regional perfusion of the airways of guinea-pig lung: a selective action of histamine on the smooth muscle of the small airways [proceedings]. Br J Pharmacol. 1977 Sep;61(1):156P–156P. [PMC free article] [PubMed] [Google Scholar]
  15. Bevan P., Bradshaw C. M., Szabadi E. The pharmacology of adrenergic neuronal responses in the cerebral cortex: evidence for excitatory alpha- and inhibitory beta-receptors. Br J Pharmacol. 1977 Apr;59(4):635–641. doi: 10.1111/j.1476-5381.1977.tb07732.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bilski A., Robertson H. H., Wale J. L. A study of the relationship between cardiac beta-adrenoceptor blockade and intrinsic sympathomimetic activity in rats depleted of catecholamines. Clin Exp Pharmacol Physiol. 1979 Jan-Feb;6(1):1–9. doi: 10.1111/j.1440-1681.1979.tb00001.x. [DOI] [PubMed] [Google Scholar]
  17. Björklund A., Cegrell L., Falck B., Ritzén M., Rosengren E. Dopamine-containing cells in sympathetic ganglia. Acta Physiol Scand. 1970 Mar;78(3):334–338. doi: 10.1111/j.1748-1716.1970.tb04668.x. [DOI] [PubMed] [Google Scholar]
  18. Black G. W. Enflurane. Br J Anaesth. 1979 Jul;51(7):627–640. doi: 10.1093/bja/51.7.627. [DOI] [PubMed] [Google Scholar]
  19. Black J. W., Duncan W. A., Durant C. J., Ganellin C. R., Parsons E. M. Definition and antagonism of histamine H 2 -receptors. Nature. 1972 Apr 21;236(5347):385–390. doi: 10.1038/236385a0. [DOI] [PubMed] [Google Scholar]
  20. Bodor N., Shek E., Higuchi T. Improved delivery through biological membranes. 1. Synthesis and properties of 1-methyl-1,6-dihydropyridine-2-carbaldoxime, a pro-drug of N-methylpyridinium-2-carbaldoxime chloride. J Med Chem. 1976 Jan;19(1):102–107. doi: 10.1021/jm00223a017. [DOI] [PubMed] [Google Scholar]
  21. Borg K. O., Fellenius E., Johansson R., Wallborg M. Pharmacokinetic studies of metoprolol-(3-h) in the rat and the dog. Acta Pharmacol Toxicol (Copenh) 1975;36(Suppl 5):104–115. doi: 10.1111/j.1600-0773.1975.tb03327.x. [DOI] [PubMed] [Google Scholar]
  22. Brown B. L., Albano J. D., Ekins R. P., Sgherzi A. M. A simple and sensitive saturation assay method for the measurement of adenosine 3':5'-cyclic monophosphate. Biochem J. 1971 Feb;121(3):561–562. doi: 10.1042/bj1210561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Brown B. L., Ekins R. P., Albano J. D. Saturation assay for cyclic AMP using endogenous binding protein. Adv Cyclic Nucleotide Res. 1972;2:25–40. [PubMed] [Google Scholar]
  24. Buckley G. A., Heading C. E., Moradian M. H. Tolerance to neostigmine in rodents and its prevention by cycloheximide treatment. J Pharm Pharmacol. 1978 May;30(5):332–334. doi: 10.1111/j.2042-7158.1978.tb13248.x. [DOI] [PubMed] [Google Scholar]
  25. Burnstock G., Cocks T., Crowe R. Evidence for purinergic innervation of the anococcygeus muscle. Br J Pharmacol. 1978 Sep;64(1):13–20. doi: 10.1111/j.1476-5381.1978.tb08635.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Bünger R., Haddy F. J., Gerlach E. Coronary responses to dilating substances and competitive inhibition by theophylline in the isolated perfused guinea pig heart. Pflugers Arch. 1975 Jul 28;358(3):213–224. doi: 10.1007/BF00587218. [DOI] [PubMed] [Google Scholar]
  27. CLELAND W. W. DITHIOTHREITOL, A NEW PROTECTIVE REAGENT FOR SH GROUPS. Biochemistry. 1964 Apr;3:480–482. doi: 10.1021/bi00892a002. [DOI] [PubMed] [Google Scholar]
  28. CREASEY N. H., GREEN A. L. 2-Hydroxyiminomethyl-N-methylpyridinium methanesulphonate (P2S), an antidote to organophosphorus poisoning. Its preparation, estimation and stability. J Pharm Pharmacol. 1959 Aug;11:485–490. doi: 10.1111/j.2042-7158.1959.tb12586.x. [DOI] [PubMed] [Google Scholar]
  29. Cavero I., Roach A. G. The effects of prazosin on the clonidine induced hypotension and bradycardia in rats and sedation in chicks [proceedings]. Br J Pharmacol. 1978 Mar;62(3):468P–469P. [PMC free article] [PubMed] [Google Scholar]
  30. Ceccarelli B., Hurlbut W. P. The effects of prolonged repetitive stimulation in hemicholinium on the frog neuromuscular junction. J Physiol. 1975 May;247(1):163–188. doi: 10.1113/jphysiol.1975.sp010926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Chan-Palay V., Jonsson G., Palay S. L. Serotonin and substance P coexist i, neurons of the rat's central nervous system. Proc Natl Acad Sci U S A. 1978 Mar;75(3):1582–1586. doi: 10.1073/pnas.75.3.1582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Clow A., Jenner P., Theodorou A., Marsden C. D. Striatal dopamine receptors become supersensitive while rats are geven trifluoperazine for six months. Nature. 1979 Mar 1;278(5699):59–61. doi: 10.1038/278059a0. [DOI] [PubMed] [Google Scholar]
  33. Cooper S. J., Crummy Y. M. Enhanced choice of familiar food in a food preference test after chlordiazepoxide administration. Psychopharmacology (Berl) 1978 Sep 15;59(1):51–56. doi: 10.1007/BF00428030. [DOI] [PubMed] [Google Scholar]
  34. Costa E., Cheney D. L., Mao C. C., Moroni F. Action of antischizophrenic drugs on the metabolism of gamma-aminobutyric acid and acetylcholine in globus pallidus, striatum and n. accumbens. Fed Proc. 1978 Aug;37(10):2408–2414. [PubMed] [Google Scholar]
  35. Cottee F., Flower R. J., Moncada S., Salmon J. A., Vane J. R. Synthesis of 6-keto-PGF1alpha by ram seminal vesicle microsomes. Prostaglandins. 1977 Sep;14(3):413–423. doi: 10.1016/0090-6980(77)90257-x. [DOI] [PubMed] [Google Scholar]
  36. Creese I., Iversen S. D. Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine. Brain Res. 1973 Jun 15;55(2):369–382. doi: 10.1016/0006-8993(73)90302-8. [DOI] [PubMed] [Google Scholar]
  37. Crews F. T., Smith C. B. Presynaptic alpha-receptor subsensitivity after long-term antidepressant treatment. Science. 1978 Oct 20;202(4365):322–324. doi: 10.1126/science.211589. [DOI] [PubMed] [Google Scholar]
  38. Da Prada M., Zürcher Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sci. 1976 Oct 15;19(8):1161–1174. doi: 10.1016/0024-3205(76)90251-4. [DOI] [PubMed] [Google Scholar]
  39. Dannan G. A., Moore R. W., Besaw L. C., Aust S. D. 2,4,5,3',4',5'-Hexabromobiphenyl is both a 3-methylcholanthrene-and a phenobarbital-type inducer of microsomal drug metabolizing enzymes. Biochem Biophys Res Commun. 1978 Nov 14;85(1):450–458. doi: 10.1016/s0006-291x(78)80063-1. [DOI] [PubMed] [Google Scholar]
  40. Davison J. S., Al-Hassani M., Crowe R., Burnstock G. The non-adrenergic, inhibitory innervation of the guinea-pig gallbladder. Pflugers Arch. 1978 Oct 18;377(1):43–49. doi: 10.1007/BF00584372. [DOI] [PubMed] [Google Scholar]
  41. Davison J. S., Fösel S. Interactions between vagus nerve stimulation and pentagastrin or secretin on the guinea pig gallbladder. Digestion. 1975;13(4):251–254. doi: 10.1159/000197715. [DOI] [PubMed] [Google Scholar]
  42. De Potter W. P. Noradrenaline storage particles in splenic nerve. Philos Trans R Soc Lond B Biol Sci. 1971 Jun 17;261(839):313–317. doi: 10.1098/rstb.1971.0062. [DOI] [PubMed] [Google Scholar]
  43. Delini-Stula A., Baumann P., Büch O. Depression of exploratory activity by clonidine in rats as a model for the detection of relative pre- and postsynaptic central noradrenergic receptor selectivity of alpha-adrenolytic drugs. Naunyn Schmiedebergs Arch Pharmacol. 1979 Jun;307(2):115–122. doi: 10.1007/BF00498452. [DOI] [PubMed] [Google Scholar]
  44. Dent J. G., Elcombe C. R., Netter K. J., Gibson J. E. Rat hepatic microsomal cytochrome(s) P-450 induced by polybrominated biphenyls. Drug Metab Dispos. 1978 Jan-Feb;6(1):96–101. [PubMed] [Google Scholar]
  45. Deschodt-Lanckman M., Robberecht P., Christophe J. Characterization of VIP-sensitive adenylate cyclase in guinea pig brain. FEBS Lett. 1977 Nov 1;83(1):76–80. doi: 10.1016/0014-5793(77)80645-5. [DOI] [PubMed] [Google Scholar]
  46. Dowling J. E., Ehinger B. The interplexiform cell system. I. Synapses of the dopaminergic neurons of the goldfish retina. Proc R Soc Lond B Biol Sci. 1978 Apr 13;201(1142):7–26. doi: 10.1098/rspb.1978.0030. [DOI] [PubMed] [Google Scholar]
  47. Doxey J. C., Everitt J. Inhibitory effects of clonidine on responses to sympathetic nerve stimulation in the pithed rat. Br J Pharmacol. 1977 Dec;61(4):559–566. doi: 10.1111/j.1476-5381.1977.tb07548.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Drazen J. M., Schneider M. W. Comparative responses of tracheal spirals and parenchymal strips to histamine and carbachol in vitro. J Clin Invest. 1978 Jun;61(6):1441–1447. doi: 10.1172/JCI109063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Drew G. M., Gower A. J., Marriott A. S. Pharmacological characterization of alpha-adrenoceptors which mediate clonidine-induced sedation [proceedings]. Br J Pharmacol. 1977 Nov;61(3):468P–468P. [PMC free article] [PubMed] [Google Scholar]
  50. Dukes M., Russell W., Walpole A. L. Potent luteolytic agents related to prostaglandin F2alpha. Nature. 1974 Jul 26;250(464):330–331. doi: 10.1038/250330a0. [DOI] [PubMed] [Google Scholar]
  51. Dukes M., Russell W., Walpole A. L. Potent luteolytic agents related to prostaglandin F2alpha. Nature. 1974 Jul 26;250(464):330–331. doi: 10.1038/250330a0. [DOI] [PubMed] [Google Scholar]
  52. Durant G. J., Duncan W. A., Ganellin C. R., Parsons M. E., Blakemore R. C., Rasmussen A. C. Impromidine (SK&F 92676) is a very potent and specific agonist for histamine H2 receptors. Nature. 1978 Nov 23;276(5686):403–405. doi: 10.1038/276403a0. [DOI] [PubMed] [Google Scholar]
  53. Emson P. C., Fahrenkrug J., Schaffalitzky de Muckadell O. B., Jessell T. M., Iversen L. L. Vasoactive intestinal polypeptide (VIP): vesicular localization and potassium evoked release from rat hypothalamus. Brain Res. 1978 Mar 17;143(1):174–178. doi: 10.1016/0006-8993(78)90762-x. [DOI] [PubMed] [Google Scholar]
  54. Ennis C., Janssen P. A., Schnieden H., Cox B. Characterization of receptors on postganglionic cholinergic neurons in the guinea-pig isolated ileum. J Pharm Pharmacol. 1979 Apr;31(4):217–221. doi: 10.1111/j.2042-7158.1979.tb13482.x. [DOI] [PubMed] [Google Scholar]
  55. Eriksson H. E., Florvall L. G. The preparation and antihypertensive activity of 4-amino-3-(2,6-dichlorobenzylidenehydrazino)-1,2,4-triazole and some related compounds. Acta Pharm Suec. 1976;13(1):79–96. [PubMed] [Google Scholar]
  56. Eyre P. Histamine H2-receptors in the sheep bronchus and cat trachea: the action of burimamide. Br J Pharmacol. 1973 Jun;48(2):321–323. doi: 10.1111/j.1476-5381.1973.tb06920.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Fantozzi R., Franconi F., Mannaioni P. F., Masini E., Moroni F. Interaction of histamine H1-and H2-receptor antagonists with histamine uptake and metabolism by guinea-pig isolated atrium and mouse neoplastic mast cells cells in vitro. Br J Pharmacol. 1975 Apr;53(4):569–574. doi: 10.1111/j.1476-5381.1975.tb07396.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Flower R. J., Blackwell G. J. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature. 1979 Mar 29;278(5703):456–459. doi: 10.1038/278456a0. [DOI] [PubMed] [Google Scholar]
  59. Fonnum F. A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem. 1975 Feb;24(2):407–409. doi: 10.1111/j.1471-4159.1975.tb11895.x. [DOI] [PubMed] [Google Scholar]
  60. Fozard J. R., Ali A. T. Receptors for 5-hydroxytryptamine on the sympathetic nerves of the rabbit heart. Naunyn Schmiedebergs Arch Pharmacol. 1978 Jan-Feb;301(3):223–235. doi: 10.1007/BF00507041. [DOI] [PubMed] [Google Scholar]
  61. Frank H., Nicholson G. J., Bayer E. Gas chromatographic--mass spectrometric analysis of optically active metabolites and drugs on a novel chiral stationary phase. J Chromatogr. 1978 Sep 1;146(2):197–206. doi: 10.1016/s0378-4347(00)81885-x. [DOI] [PubMed] [Google Scholar]
  62. Friggi A., Chevalier-Cholat A. M., Bodard H. Effets d'un inhibiteur béta-adrénergique, l'aténolol, sur l'activité efférente du nerf rénal chez le lapin. Experientia. 1977 Sep 15;33(9):1207–1208. doi: 10.1007/BF01922332. [DOI] [PubMed] [Google Scholar]
  63. Fuller T. A., Olney J. W. Effects of morphine or naloxone on kainic acid neurotoxicity. Life Sci. 1979 May 7;24(19):1793–1798. doi: 10.1016/0024-3205(79)90069-9. [DOI] [PubMed] [Google Scholar]
  64. GINSBORG B. L., WARRINER J. The isolated chick biventer cervicis nerve-muscle preparation. Br J Pharmacol Chemother. 1960 Sep;15:410–411. doi: 10.1111/j.1476-5381.1960.tb01264.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Geller H. M., Taylor D. A., Hoffer B. J. Benzodiazepines and central inhibitory mechanisms. Naunyn Schmiedebergs Arch Pharmacol. 1978 Sep;304(2):81–88. doi: 10.1007/BF00495542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Giachetti A., Said S. I., Reynolds R. C., Koniges F. C. Vasoactive intestinal polypeptide in brain: localization in and release from isolated nerve terminals. Proc Natl Acad Sci U S A. 1977 Aug;74(8):3424–3428. doi: 10.1073/pnas.74.8.3424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Gillespie J. S. The rat anococcygeus muscle and its response to nerve stimulation and to some drugs. Br J Pharmacol. 1972 Jul;45(3):404–416. doi: 10.1111/j.1476-5381.1972.tb08097.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Goldberg L. I. Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev. 1972 Mar;24(1):1–29. [PubMed] [Google Scholar]
  69. Gordon S., Todd J., Cohn Z. A. In vitro synthesis and secretion of lysozyme by mononuclear phagocytes. J Exp Med. 1974 May 1;139(5):1228–1248. doi: 10.1084/jem.139.5.1228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Gryglewski R. J., Bunting S., Moncada S., Flower R. J., Vane J. R. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins. 1976 Nov;12(5):685–713. doi: 10.1016/0090-6980(76)90047-2. [DOI] [PubMed] [Google Scholar]
  71. Gubler H. U., Baggiolini M. Pharmacological properties of proquazone. Scand J Rheumatol Suppl. 1978;(21):8–11. doi: 10.3109/03009747809095666. [DOI] [PubMed] [Google Scholar]
  72. HARDISTY R. M., HUTTON R. A. THE KAOLIN CLOTTING TIME OF PLATELET-RICH PLASMA: A TEST OF PLATELET FACTOR-3 AVAILABILITY. Br J Haematol. 1965 May;11:258–268. doi: 10.1111/j.1365-2141.1965.tb06586.x. [DOI] [PubMed] [Google Scholar]
  73. HUMPHREY J. H., MOTA I. The mechanism of anaphylaxis: specificity of antigen-induced mast cell damage in anaphylaxis in the guinea pig. Immunology. 1959 Jan;2(1):31–43. [PMC free article] [PubMed] [Google Scholar]
  74. Haas H. L., Anderson E. G., Hösli L. Histamine and metabolites: their effects and interactions with convulsants on brain stem neurones. Brain Res. 1973 Mar 15;51:269–278. doi: 10.1016/0006-8993(73)90378-8. [DOI] [PubMed] [Google Scholar]
  75. Haefliger W., Hauser D. Isolierung und Strukturaufklärung von 11-Desacetoxy-wortmannin. Helv Chim Acta. 1973;56(8):2901–2904. doi: 10.1002/hlca.19730560828. [DOI] [PubMed] [Google Scholar]
  76. Hamberg M., Samuelsson B. Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci U S A. 1974 Sep;71(9):3400–3404. doi: 10.1073/pnas.71.9.3400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Hess R., Stäubli W., Riess W. Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat. Nature. 1965 Nov 27;208(5013):856–858. doi: 10.1038/208856a0. [DOI] [PubMed] [Google Scholar]
  78. Higgs G. A., Flower R. J., Vane J. R. A new approach to anti-inflammatory drugs. Biochem Pharmacol. 1979 Jun 15;28(12):1959–1961. doi: 10.1016/0006-2952(79)90651-8. [DOI] [PubMed] [Google Scholar]
  79. Higgs G. A., Harvey E. A., Ferreira S. H., Vane J. R. The effects of antiinflammatory drugs on the production of prostaglandins in vivo. Adv Prostaglandin Thromboxane Res. 1976;1:105–110. [PubMed] [Google Scholar]
  80. Holland P., Parkes D. C. Plasma concentrations of the oxime Pralidoxime Mesylate (P2S) after repeated oral and intramuscular administration. Br J Ind Med. 1976 Feb;33(1):43–46. doi: 10.1136/oem.33.1.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Holtzman S. G. Suppression of appetitive behavior in the rat by naloxone: lack of effect of prior morphine dependence. Life Sci. 1979 Jan 15;24(3):219–226. doi: 10.1016/0024-3205(79)90222-4. [DOI] [PubMed] [Google Scholar]
  82. Hong S. L., Levine L. Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids. Proc Natl Acad Sci U S A. 1976 May;73(5):1730–1734. doi: 10.1073/pnas.73.5.1730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Hope W., McCulloch M. W., Story D. F., Rand M. J. Effects of pimozide on noradrenergic transmission in rabbit isolated ear arteries. Eur J Pharmacol. 1977 Nov 15;46(2):101–111. doi: 10.1016/0014-2999(77)90245-x. [DOI] [PubMed] [Google Scholar]
  84. Horn A. S. Structure activity relations for the inhibition of 5-HT uptake into rat hypothalamic homogenates by serotonin and tryptamine analogues. J Neurochem. 1973 Oct;21(4):883–888. doi: 10.1111/j.1471-4159.1973.tb07533.x. [DOI] [PubMed] [Google Scholar]
  85. Hoult J. R., Moore P. K. Pathways of prostaglandin F2alpha metabolism in mammalian kidneys. Br J Pharmacol. 1977 Dec;61(4):615–626. doi: 10.1111/j.1476-5381.1977.tb07555.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Hughes J., Kosterlitz H. W., Smith T. W. The distribution of methionine-enkephalin and leucine-enkephalin in the brain and peripheral tissues. Br J Pharmacol. 1977 Dec;61(4):639–647. doi: 10.1111/j.1476-5381.1977.tb07557.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Hughes J., Kosterlitz H. W., Sosa R. P. Enkephalin release from the myenteric plexus of the guinea-pig small intestine in the presence of cycloheximide [proceedings]. Br J Pharmacol. 1978 Jun;63(2):397P–397P. [PMC free article] [PubMed] [Google Scholar]
  88. Hughes R. L., Mathie R. T., Campbell D., Fitch W. Effect of hypercarbia on hepatic blood flow and oxygen consumption in the greyhound. Br J Anaesth. 1979 Apr;51(4):289–296. doi: 10.1093/bja/51.4.289. [DOI] [PubMed] [Google Scholar]
  89. Hökfelt T., Ljungdahl A., Steinbusch H., Verhofstad A., Nilsson G., Brodin E., Pernow B., Goldstein M. Immunohistochemical evidence of substance P-like immunoreactivity in some 5-hydroxytryptamine-containing neurons in the rat central nervous system. Neuroscience. 1978;3(6):517–538. doi: 10.1016/0306-4522(78)90017-9. [DOI] [PubMed] [Google Scholar]
  90. Imbs J. L., Miesch F., Schwartz J., Velly J., Leclerc G., Mann A., Wermuth C. G. A potent new beta2-adrenoceptor blocking agent. Br J Pharmacol. 1977 Jul;60(3):357–362. doi: 10.1111/j.1476-5381.1977.tb07508.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Inman W. H., Mushin W. W. Jaundice after repeated exposure to halothane: a further analysis of reports to the Committee on Safety of Medicines. Br Med J. 1978 Nov 25;2(6150):1455–1456. doi: 10.1136/bmj.2.6150.1455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Iversen L. L. Dopamine receptors in the brain. Science. 1975 Jun 13;188(4193):1084–1089. doi: 10.1126/science.2976. [DOI] [PubMed] [Google Scholar]
  93. Kanazawa I., Jessell T. Post mortem changes and regional distribution of substance P in the rat and mouse nervous system. Brain Res. 1976 Nov 26;117(2):362–367. doi: 10.1016/0006-8993(76)90748-4. [DOI] [PubMed] [Google Scholar]
  94. Karoum F., Moyer-Schwing J., Potkin S. G., Wyatt R. J. Presence of free, sulfate and glucuronide conjugated 3-methoxy-4-hydroxyphenylglycol (MHPG) in human brain, cerebrospinal fluid and plasma. Brain Res. 1977 Apr 15;125(2):333–339. doi: 10.1016/0006-8993(77)90626-6. [DOI] [PubMed] [Google Scholar]
  95. Kebabian J. W., Petzold G. L., Greengard P. Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor". Proc Natl Acad Sci U S A. 1972 Aug;69(8):2145–2149. doi: 10.1073/pnas.69.8.2145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Kohli J. D., Goldberg L. I., Volkman P. H., Cannon J. G. N,N-Di-n-propyl dopamine: a qualitatively different dopamine vascular agonist. J Pharmacol Exp Ther. 1978 Oct;207(1):16–22. [PubMed] [Google Scholar]
  97. Konishi S., Otsuka M. The effects of substance P and other peptides on spinal neurons of the frog. Brain Res. 1974 Jan 18;65(3):397–410. doi: 10.1016/0006-8993(74)90231-5. [DOI] [PubMed] [Google Scholar]
  98. Kukovetz W. R., Pöch G. Inhibition of cyclic-3',5'-nucleotide-phosphodiesterase as a possible mode of action of papaverine and similarly acting drugs. Naunyn Schmiedebergs Arch Pharmakol. 1970;267(2):189–194. doi: 10.1007/BF00999402. [DOI] [PubMed] [Google Scholar]
  99. LEDUC E. H., TANAKA N. A study of the cellular distribution of Forssman antigen in various species. J Immunol. 1956 Sep;77(3):198–212. [PubMed] [Google Scholar]
  100. LEE Y. P., TAKEMORI A. E., LARDY H. Enhanced oxidation of alpha-glycerophosphate by mitochondria of thyroid-fed rats. J Biol Chem. 1959 Nov;234:3051–3054. [PubMed] [Google Scholar]
  101. Lanthorn T., Isaacson R. L. Studies of kainate-induced wet-dog shakes in the rat. Life Sci. 1978 Jan;22(2):171–177. doi: 10.1016/0024-3205(78)90534-9. [DOI] [PubMed] [Google Scholar]
  102. Lenicque P. M., Wepierre J., Cohen Y. Protection by 4-amino-hex-5-enoic acid (gamma-vinyl GABA) and hypobaric hypoxia against kainic acid neurotoxicity. Psychopharmacology (Berl) 1979;66(1):51–53. doi: 10.1007/BF00431989. [DOI] [PubMed] [Google Scholar]
  103. Levy B., Wilkenfeld B. E. An analysis of selective beta receptor blockade. Eur J Pharmacol. 1969 Feb;5(3):227–234. doi: 10.1016/0014-2999(69)90142-3. [DOI] [PubMed] [Google Scholar]
  104. Lewis G. P., Piper P. J. Inhibition of release of prostaglandins as an explanation of some of the actions of anti-inflammatory corticosteroids. Nature. 1975 Mar 27;254(5498):308–311. doi: 10.1038/254308a0. [DOI] [PubMed] [Google Scholar]
  105. Ljungberg T., Ungerstedt U. Different behavioural patterns induced by apomorphine: evidence that the method of administration determines the behavioural response to the drug. Eur J Pharmacol. 1977 Nov 1;46(1):41–50. doi: 10.1016/0014-2999(77)90142-x. [DOI] [PubMed] [Google Scholar]
  106. Lokhandwala M. F., Buckley J. P. Presynaptic dopamine receptors as mediators of dopamine-induced inhibition of neurogenic vasoconstriction. Eur J Pharmacol. 1977 Oct 1;45(3):305–309. doi: 10.1016/0014-2999(77)90015-2. [DOI] [PubMed] [Google Scholar]
  107. Long J. P., Heintz S., Cannon J. G., Kim J. Inhibition of the sympathetic nervous system by 5,6-dihydroxy-2-dimethylamino tetralin (M-7), apomorphine and dopamine. J Pharmacol Exp Ther. 1975 Feb;192(2):336–342. [PubMed] [Google Scholar]
  108. MATHIAS A. P., ROSS D. M., SCHACHTER M. The distribution 5-hydroxytryptamine, tetramethyammonium, homarine, and other substances in sea anemones. J Physiol. 1960 May;151:296–311. doi: 10.1113/jphysiol.1960.sp006439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Marcus A. J. The role of lipids in platelet function: with particular reference to the arachidonic acid pathway. J Lipid Res. 1978 Sep;19(7):793–826. [PubMed] [Google Scholar]
  110. Marshall I. An inhibitory histamine H2-receptor in the mouse vas deferens [proceedings]. Br J Pharmacol. 1978 Mar;62(3):447P–447P. [PMC free article] [PubMed] [Google Scholar]
  111. Mathé A. A., Strandberg K., Fredholm B. Antagonism of prostaglandin F 2 induced bronchoconstriction and blood pressure changes by polyphloretin phosphate in the guinea-pig and cat. J Pharm Pharmacol. 1972 May;24(5):378–382. doi: 10.1111/j.2042-7158.1972.tb09011.x. [DOI] [PubMed] [Google Scholar]
  112. May J. E., Frank M. M. Complement-mediated tissue damage: contribution of the classical and alternate complement pathways in the Forssman reaction. J Immunol. 1972 Jun;108(6):1517–1525. [PubMed] [Google Scholar]
  113. Meek J. L., Neff N. H. Fluorometric estimation of 4-hydroxy-3-methoxyphenylethyleneglycol sulphate in brain. Br J Pharmacol. 1972 Jul;45(3):435–441. doi: 10.1111/j.1476-5381.1972.tb08099.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Meiri U., Rahamimoff R. Activation of transmitter release by strontium and calcium ions at the neuromuscular junction. J Physiol. 1971 Jul;215(3):709–726. doi: 10.1113/jphysiol.1971.sp009493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Michaluk J., Antkiewicz-Michaluk L. The effect of neuroleptics of serotonergic system of the rat brain. Pol J Pharmacol Pharm. 1978 Mar-Jun;30(2-3):233–243. [PubMed] [Google Scholar]
  116. Moncada S., Gryglewski R., Bunting S., Vane J. R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 1976 Oct 21;263(5579):663–665. doi: 10.1038/263663a0. [DOI] [PubMed] [Google Scholar]
  117. Murray S., Baillie T. A., Davies D. S. A non-enzymic procdure for the quantitative analysis of (3-methoxy-4-sulphoxyphenyl)ethylene glycol(MHPG sulphate) in human urine using stable isotope dilution and gas chromatography-mass spectrometry. J Chromatogr. 1977 Nov 1;143(6):541–551. doi: 10.1016/s0378-4347(00)81310-9. [DOI] [PubMed] [Google Scholar]
  118. Otsuka M., Konishi S. Release of substance P-like immunoreactivity from isolated spinal cord of newborn rat. Nature. 1976 Nov 4;264(5581):83–84. doi: 10.1038/264083a0. [DOI] [PubMed] [Google Scholar]
  119. Parsons M. E., Owen D. A., Ganellin C. R., Durant G. J. Dimaprit -(S-[3-(N,N-dimethylamino)prophyl]isothiourea) - a highly specific histamine H2 -receptor agonist. Part 1. Pharmacology. Agents Actions. 1977 Mar;7(1):31–37. doi: 10.1007/BF01964878. [DOI] [PubMed] [Google Scholar]
  120. Paton W. D., Zar M. A. The origin of acetylcholine released from guinea-pig intestine and longitudinal muscle strips. J Physiol. 1968 Jan;194(1):13–33. doi: 10.1113/jphysiol.1968.sp008392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Pawlik W., Shepherd A. P., Jacobson E. D. Effect of vasoactive agents on intestinal oxygen consumption and blood flow in dogs. J Clin Invest. 1975 Aug;56(2):484–490. doi: 10.1172/JCI108115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Petty M. A., Reid J. L. Catecholamine synthesizing enzymes in brain stem and hypothalamus during the development of renovascular hypertension. Brain Res. 1979 Mar 16;163(2):277–288. doi: 10.1016/0006-8993(79)90355-x. [DOI] [PubMed] [Google Scholar]
  123. Phillis J. W., Tebecis A. K., York D. H. Histamine and some antihistamines: their actions on cerebral cortical neurones. Br J Pharmacol Chemother. 1968 Jul;33(3):426–440. doi: 10.1111/j.1476-5381.1968.tb00492.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Poschel B. P. A simple and specific screen for benzodiazepine-like drugs. Psychopharmacologia. 1971;19(2):193–198. doi: 10.1007/BF00402642. [DOI] [PubMed] [Google Scholar]
  125. Quik M., Iversen L. L., Bloom S. R. Effect of vasoactive intestinal peptide (VIP) and other peptides on cAMP accumulation in rat brain. Biochem Pharmacol. 1978;27(18):2209–2213. doi: 10.1016/0006-2952(78)90079-5. [DOI] [PubMed] [Google Scholar]
  126. RUTLAND J. P. The effect of some oximes in sarin poisoning. Br J Pharmacol Chemother. 1958 Dec;13(4):399–403. doi: 10.1111/j.1476-5381.1958.tb00228.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Raisman R., Briley M., Langer S. Z. High-affinity 3H-imipramine binding in rat cerebral cortex. Eur J Pharmacol. 1979 Mar 1;54(3):307–308. doi: 10.1016/0014-2999(79)90092-x. [DOI] [PubMed] [Google Scholar]
  128. Randrup A., Munkvad I. Stereotyped activities produced by amphetamine in several animal species and man. Psychopharmacologia. 1967;11(4):300–310. doi: 10.1007/BF00404607. [DOI] [PubMed] [Google Scholar]
  129. Rigter H., Van Riezen H., Wren A., Schnieden H. Pharmacological validation of a new test for the detection of antidepressant activity of drugs [proceedings]. Br J Pharmacol. 1977 Mar;59(3):451P–452P. [PMC free article] [PubMed] [Google Scholar]
  130. Rocha E Silva M., Jr, Rosenberg M. The release of vasopressin in response to haemorrhage and its role in the mechanism of blood pressure regulation. J Physiol. 1969 Jun;202(3):535–557. doi: 10.1113/jphysiol.1969.sp008826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Rose S. P., Sinha A. K. Rapidly labelling and exported neuronal protein; [3H]fucose as a precursor, and effects of cycloheximide and colchicine. J Neurochem. 1976 Oct;27(4):963–966. doi: 10.1111/j.1471-4159.1976.tb05162.x. [DOI] [PubMed] [Google Scholar]
  132. Rouot B., Leclerc G., Bieth N., Wermuth C. G., Schwartz J. Etude pharmacologique de la para-aminoclonidine, sympathomimétique alpha. C R Acad Sci Hebd Seances Acad Sci D. 1978 Mar 20;286(11):909–912. [PubMed] [Google Scholar]
  133. Ruegamer W. R., Ryan N. T., Richert D. A., Westerfeld W. W. The effects of p-chlorophenoxyisobutyrate on the turnover rate and distribution of thyroid hormone in the rat. Biochem Pharmacol. 1969 Mar;18(3):613–624. doi: 10.1016/0006-2952(69)90086-0. [DOI] [PubMed] [Google Scholar]
  134. STEPHENSON R. P. A modification of receptor theory. Br J Pharmacol Chemother. 1956 Dec;11(4):379–393. doi: 10.1111/j.1476-5381.1956.tb00006.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. SUNDWALL A. Minimum concentrations of N-methylpyridinium-2-aldoxime methane sulphonate (P2S) which reverse neuromuscular block. Biochem Pharmacol. 1961 Dec;8:413–417. doi: 10.1016/0006-2952(61)90059-4. [DOI] [PubMed] [Google Scholar]
  136. Sahakian B. J., Robbins T. W. Potentiation of locomotor activity and modification of sterotypy by starvation in adomorphine treated rats. Neuropharmacology. 1975 Apr;14(4):251–257. doi: 10.1016/0028-3908(75)90070-2. [DOI] [PubMed] [Google Scholar]
  137. Said S. I., Rosenberg R. N. Vasoactive intestinal polypeptide: abundant immunoreactivity in neural cell lines and normal nervous tissue. Science. 1976 May 28;192(4242):907–908. doi: 10.1126/science.1273576. [DOI] [PubMed] [Google Scholar]
  138. Sanner J. H. Antagonism of prostaglandin E2 by 1-acetyl-2-(8-chloro-10,11-dihydrodibenz (b,f) (1,4) oxazepine-10-carbonyl) hydrazine (SC-19220). Arch Int Pharmacodyn Ther. 1969 Jul;180(1):46–56. [PubMed] [Google Scholar]
  139. Schechter Y., Weinstock M. Beta-adrenoceptor blocking agents and responses to adrenaline and 5-hydroxytryptamine in rat isolated stomach and uterus. Br J Pharmacol. 1974 Oct;52(2):283–287. doi: 10.1111/j.1476-5381.1974.tb09711.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Schmid P. G., Abboud F. M., Wendling M. G., Ramberg E. S., Mark A. L., Heistad D. D., Eckstein J. W. Regional vascular effects of vasopressin: plasma levels and circulatory responses. Am J Physiol. 1974 Nov;227(5):998–1004. doi: 10.1152/ajplegacy.1974.227.5.998. [DOI] [PubMed] [Google Scholar]
  141. Schnyder J., Baggiolini M. Role of phagocytosis in the activation of macrophages. J Exp Med. 1978 Dec 1;148(6):1449–1457. doi: 10.1084/jem.148.6.1449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Schnyder J., Baggiolini M. Secretion of lysosomal hydrolases by stimulated and nonstimulated macrophages. J Exp Med. 1978 Aug 1;148(2):435–450. doi: 10.1084/jem.148.2.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Schümann H. J., Endoh M. alpha-Adrenoceptors in the ventricular myocardium: clonidine, naphazoline and methoxamine as partial alpha-agonists exerting a competitive dualism in action to phenylephrine. Eur J Pharmacol. 1976 Apr;36(2):413–421. doi: 10.1016/0014-2999(76)90095-9. [DOI] [PubMed] [Google Scholar]
  144. Sethy V. H., Van Woert M. H. Regulation of striatal acetylcholine concentration by dopamine receptors. Nature. 1974 Oct 11;251(5475):529–530. doi: 10.1038/251529a0. [DOI] [PubMed] [Google Scholar]
  145. Shearer M. J., Barkhan P., Webster G. R. Absorption and excretion of an oral dose of tritiated vitamin K1 in man. Br J Haematol. 1970 Mar;18(3):297–308. doi: 10.1111/j.1365-2141.1970.tb01444.x. [DOI] [PubMed] [Google Scholar]
  146. Shek E., Higuchi T., Bodor N. Improved delivery through biological membranes. 3. Delivery of N-methylpyridinium-2-carbaldoxime chloride through the blood-brain barrier in its dihydropyridine pro-drug form. J Med Chem. 1976 Jan;19(1):113–117. doi: 10.1021/jm00223a019. [DOI] [PubMed] [Google Scholar]
  147. Shepherd A. M., Hewick D. S., Moreland T. A., Stevenson I. H. Age as a determinant of sensitivity to warfarin. Br J Clin Pharmacol. 1977 Jun;4(3):315–320. doi: 10.1111/j.1365-2125.1977.tb00719.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Shepherd A. P., Pawlik W., Mailman D., Burks T. F., Jacobson E. D. Effects of vasoconstrictors on intestinal vascular resistance and oxygen extraction. Am J Physiol. 1976 Feb;230(2):298–305. doi: 10.1152/ajplegacy.1976.230.2.298. [DOI] [PubMed] [Google Scholar]
  149. Shih T. M., Hanin I. Chronic lead exposure in immature animals: neurochemical correlates. Life Sci. 1978 Sep 4;23(9):877–888. doi: 10.1016/0024-3205(78)90212-6. [DOI] [PubMed] [Google Scholar]
  150. Sieck M. H. The role of the olfactory system in avoidance learning and activity. Physiol Behav. 1972 Apr;8(4):705–710. doi: 10.1016/0031-9384(72)90099-6. [DOI] [PubMed] [Google Scholar]
  151. Silinsky E. M. Enhancement by an antagonist of transmitter release from frog motor nerve terminals. Br J Pharmacol. 1978 Jul;63(3):485–493. doi: 10.1111/j.1476-5381.1978.tb07802.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Simon J. R., Atweh S., Kuhar M. J. Sodium-dependent high affinity choline uptake: a regulatory step in the synthesis of acetylcholine. J Neurochem. 1976 May;26(5):909–922. doi: 10.1111/j.1471-4159.1976.tb06472.x. [DOI] [PubMed] [Google Scholar]
  153. Slonim A. D. Valentina Abdullaevna Isabaeva (k 50-letiiu so dnia rozhdeniia). Zdravookhr Kirg. 1977 Nov-Dec;0(6):54–56. [PubMed] [Google Scholar]
  154. Stahl S. M. The human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. Arch Gen Psychiatry. 1977 May;34(5):509–516. doi: 10.1001/archpsyc.1977.01770170019001. [DOI] [PubMed] [Google Scholar]
  155. Steiner A. L., Pagliara A. S., Chase L. R., Kipnis D. M. Radioimmunoassay for cyclic nucleotides. II. Adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in mammalian tissues and body fluids. J Biol Chem. 1972 Feb 25;247(4):1114–1120. [PubMed] [Google Scholar]
  156. Taylor K. M. Comparison of the antihistaminic effect of burimamide and mepyramine and their effect on the activity of histamine methyltransferase. Biochem Pharmacol. 1973 Nov 1;22(21):2775–2776. doi: 10.1016/0006-2952(73)90141-x. [DOI] [PubMed] [Google Scholar]
  157. Thorner M. O. Dopamine is an important neurotransmitter in the autonomic nervous system. Lancet. 1975 Mar 22;1(7908):662–665. doi: 10.1016/s0140-6736(75)91762-6. [DOI] [PubMed] [Google Scholar]
  158. Turner S. R., Tainer J. A., Lynn W. S. Biogenesis of chemotactic molecules by the arachidonate lipoxygenase system of platelets. Nature. 1975 Oct 23;257(5528):680–681. doi: 10.1038/257680a0. [DOI] [PubMed] [Google Scholar]
  159. Unkeless J. C., Gordon S., Reich E. Secretion of plasminogen activator by stimulated macrophages. J Exp Med. 1974 Apr 1;139(4):834–850. doi: 10.1084/jem.139.4.834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. Vargaftig B. B. The inhibition of cyclo-oxygenase of rabbit platelets by aspirin is prevented by salicylic acid and by phenanthrolines. Eur J Pharmacol. 1978 Aug 1;50(3):231–241. doi: 10.1016/0014-2999(78)90355-2. [DOI] [PubMed] [Google Scholar]
  161. Vassalli J. D., Hamilton J., Reich E. Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides. Cell. 1976 Jun;8(2):271–281. doi: 10.1016/0092-8674(76)90011-8. [DOI] [PubMed] [Google Scholar]
  162. WATON N. G. Studies on mammalian histidine decarboxylase. Br J Pharmacol Chemother. 1956 Jun;11(2):119–127. doi: 10.1111/j.1476-5381.1956.tb01039.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. WATON N. G. UPTAKE AND FORMATION OF HISTAMINE BY CAT TISSUES. J Physiol. 1964 Aug;172:475–481. doi: 10.1113/jphysiol.1964.sp007433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Ward D., Young J. M. Ligand binding to muscarinic receptors in intact longitudinal muscle strips from guinea-pig intestine. Br J Pharmacol. 1977 Oct;61(2):189–197. doi: 10.1111/j.1476-5381.1977.tb08404.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Weitering J. G., Krijgsheld K. R., Mulder G. J. The availability of inorganic sulphate as a rate limiting factor in the sulphate conjugation of xenobiotics in the rat? Sulphation and glucuronidation of phenol. Biochem Pharmacol. 1979 Mar 15;28(6):757–762. doi: 10.1016/0006-2952(79)90355-1. [DOI] [PubMed] [Google Scholar]
  166. Welton A. F., Aust S. D. Multiplicity of cytochrome P450 hemoproteins in rat liver microsomes. Biochem Biophys Res Commun. 1974 Feb 27;56(4):898–906. doi: 10.1016/s0006-291x(74)80273-1. [DOI] [PubMed] [Google Scholar]
  167. Whalley E. T., Riley A. J. The effect of aprotinin on luteolytic and uterine contractile mechanisms in the pregnant rat at term. J Reprod Fertil. 1979 Mar;55(2):377–384. doi: 10.1530/jrf.0.0550377. [DOI] [PubMed] [Google Scholar]
  168. Wiesinger D., Gubler H. U., Haefliger W., Hauser D. Antiinflammatory activity of the new mould metabolite 11-desacetoxy-wortmannin and of some of its derivatives. Experientia. 1974 Feb 15;30(2):135–136. doi: 10.1007/BF01927691. [DOI] [PubMed] [Google Scholar]
  169. Wong D. T., Horng J. S., Bymaster F. P., Hauser K. L., Molloy B. B. A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. Life Sci. 1974 Aug 1;15(3):471–479. doi: 10.1016/0024-3205(74)90345-2. [DOI] [PubMed] [Google Scholar]
  170. Worcel M. Relationship between the direct inhibitory effect of hydralazine and propildazine on arterial smooth muscle contractility and sympathetic innervation. J Pharmacol Exp Ther. 1978 Nov;207(2):320–330. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES